IV, intravenous

A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
P Durez, A Nzeusseu Toukap, B R Lauwerys, D H Manicourt, P Verschueren, R Westhovens, J-P Devogelaer, F A Houssiau

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1069-1074; DOI: 10.1136/ard.2003.012914
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
L Barile-Fabris, R Ariza-Andraca, L Olguín-Ortega, L J Jara, A Fraga-Mouret, J M Miranda-Limón, J Fuentes de la Mata, P Clark, F Vargas, J Alocer-Varela

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 620-625; DOI: 10.1136/ard.2004.025528
Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs
W W Bolten

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 7-13; DOI: 10.1136/ard.2005.036269
Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis
T J A Lehman, B S Edelheit, K B Onel

Annals of the Rheumatic Diseases Mar 2004, 63 (3) 321-323; DOI: 10.1136/ard.2003.008342

Main menu